Browsing by Sponsor/Funder Univ of Sydney (original funder Amgen Inc)
Showing results 1 to 2 of 2
| Issue Date | Title | Author(s) |
|---|---|---|
| 27-Aug-2019 | Correction: Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial (vol 73, pg 2961, 2019) | Charytan, DM; Sabatine, MS; Pedersen, TR; Park, J-G; Pineda, AL, et al |
| Aug-2021 | LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial. | Sever, P; Gouni-Berthold, I; Keech, A; Giugliano, R; Pedersen, TR, et al |